Peptide GradingKey benefits
- Improved nerve symptoms in small human trials
- Does not raise red blood cells like EPO
- Studied in sarcoidosis and diabetic neuropathy
Regulatory activity
Phase I–II Clinical Trials
Early-stage human trials
Route
Subcutaneous
Often studied away from meals; timing varies by protocol.
Cycle
Varies by study
Typical duration
Storage
-20°C lyophilized · 2–8°C once reconstituted
Follow vendor guidance
Marketplace
Compare all ARA-290 vendors
Prices per size, coupon codes, lab reports and shipping.
| Vendor | Price | Coupon | Lab test | Shipping | |
|---|---|---|---|---|---|
StudzPeptides 10 mg | $29.99 Lowest price$3.00/mg | Not on file | 2-3 days
| Buy | |
 99 Purity Peptides 10 mg | $44.99 $4.50/mg | 1 COA | 3–7 days
| Buy | |
 Pure Peptides 8 mg | $47.00 $5.88/mg | 1 COA | 2–3 days
| Buy | |
 Eon Peptides 10 mg | $50.00 $5.00/mg | Not on file | 1–2 days
| Buy | |
 Evolve Peptides 10 mg | $53.90 $5.39/mg | Not on file | 2-5 business days
| Buy | |
$55.00 $5.50/mg | Not on file | 1-3 days
| Buy | ||
 Vantage Aminos 10 mg | $59.90 $5.99/mg | Not on file | 2-days
| Buy | |
Vitality Chems 10 mg | $67.99 $6.80/mg | Not on file | Ships from US fulfillment within 5 business days of payment; 2–5 business days transit
| Buy |
United States
Canada- Vitality Chems
10 mg · Ships from US fulfillment within 5 business days of payment; 2–5 business days transit
$67.99
What the research reports
Research Benefits of ARA-290
What published research has reported so far. These are research findings, not promised results.
Improved nerve symptoms in small human trials
Does not raise red blood cells like EPO
Studied in sarcoidosis and diabetic neuropathy
What the evidence shows
ARA-290 has been tested in small phase 2 trials, mainly for small fiber neuropathy linked to sarcoidosis and type 2 diabetes, with some improvement in symptoms and nerve measures. These trials were small and it has not completed larger studies or approval.
Safety and regulatory position
Not approved · phase 2 trialsARA-290 is not approved as a medicine. It was generally well tolerated in its small human trials, but long-term safety has not been studied. Vendors sell it for laboratory research use only.
FAQ
Frequently asked questions.
Cibinetide is the drug name for ARA-290.